The FDA determined this week that Cordis’ recent recall of several versions of its Super Torque angiographic catheters meet the criteria of a Class I recall, a label reserved for those the ...

Separately, Cordis said it was recalling its line of LuSee TLC Steerable Guidewires, single-use disposable devices that assist in the precise positioning of angioplasty catheters within coronary ...

FREMONT, Calif.--(BUSINESS WIRE)-- Cordis Corporation today announced it has received clearance from the Food and Drug Administration of its latest innovation in guiding catheters: the ADROIT TM 6F ...

SAN FRANCISCO--(BUSINESS WIRE)--Cordis Corporation today announced EMPIRA™ and EMPIRA™ NC RX PTCA Dilatation Catheters have received 510(k) regulatory clearance for the treatment of coronary ...

The FDA has cleared Cordis' EMPIRA and EMPIRA NC RX PTCA dilatation catheters for the treatment of coronary artery disease. The U.S. launch is expected early next year. "The EMPIRA Balloon ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cordis Corporation is pleased to announce the launch of SLEEK® OTW Catheter, a new .014” Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter ...

In a sense, the workers are helping to save lives. The Cordis de Mexico plant makes catheters and stents used to treat various circulatory system problems for Cordis Corp., a Miami Lakes, Fla.-based ...

The Arklow-based manufacturer of cardiac intervention devices has agreed to supply its latest balloon catheter to the US group's Cordis subsidiary ... it raised a further €4.4 million in a ...

MEDICAL supplies group QT Vascular said on Friday it has signed an amendment to its distribution agreement with Cordis Corporation. The revised deal allows QT Vascular to sell its Chocolate PTA ...